Analysed BELLEVUE LIFE SCIENCES-WRNT (OSRHW:NASDAQ) News Sources
OSR Holdings Eliminates $2.02 Million Warrant Overhang with Premium-Priced Convertible Note
09-04-2026
yahoo.com
OSR Holdings Executes Definitive $815 Million Global License Agreement for VXM01 with BCM Europe
29-04-2026
yahoo.com
OSR Holdings to Present VXM01 Licensing Agreement at Emerging Growth Conference May 7, 2026
30-04-2026
yahoo.com
Emerging Growth Research Issues Flash Report on OSR Holdings, Reaffirms Buy-Emerging Rating and $10.00 Price Target
05-05-2026
yahoo.com
OSR Holdings Acquires Full VXM01 Intellectual Property Portfolio in $30 Million Transaction
27-05-2026
yahoo.com
OSR Health Announces Shareholder Loyalty Program to Reward Conviction Holders With Additional Shares
25-06-2026
yahoo.com
Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target
02-07-2026
yahoo.com
CORRECTION FROM SOURCE: Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target
02-07-2026
yahoo.com
What is the current price of BELLEVUE LIFE SCIENCES-WRNT (OSRHW:NASDAQ)?
The current price of BELLEVUE LIFE SCIENCES-WRNT (OSRHW:NASDAQ) is $0.044.
BELLEVUE LIFE SCIENCES-WRNT (OSRHW:NASDAQ) absolute price change since previous trading day?
The absolute price change of BELLEVUE LIFE SCIENCES-WRNT (OSRHW:NASDAQ) since the previous trading day is $-0.0038.
BELLEVUE LIFE SCIENCES-WRNT (OSRHW:NASDAQ) percentage price change since previous trading day?
The percentage price change of BELLEVUE LIFE SCIENCES-WRNT (OSRHW:NASDAQ) since the previous trading day is -7.9498%.
What is the most recent average sentiment score for BELLEVUE LIFE SCIENCES-WRNT (OSRHW:NASDAQ)?
The most recent average sentiment score for BELLEVUE LIFE SCIENCES-WRNT (OSRHW:NASDAQ) is 59 out of 100.
What is the most recent average sentiment for BELLEVUE LIFE SCIENCES-WRNT (OSRHW:NASDAQ)?
The most recent sentiment for BELLEVUE LIFE SCIENCES-WRNT (OSRHW:NASDAQ) is .
SEC-8K** Filing Available For BELLEVUE LIFE SCIENCES-WRNT (OSRHW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.